Hepatitis C and Cigarette Smoking Behavior: Themes From Focus Groups
- 29 February 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 26 (8) , 1029-1037
Abstract
Introduction: People with chronic hepatitis C virus (HCV; PWHC) use cigarettes at a much higher prevalence than other individuals, and smoking can exacerbate the harms specifically related to HCV (eg, hepatocellular carcinoma). Little is known about factors related to cigarette use among PWHC. Aims and Methods: This study examined focus group data to explore beliefs and behaviors related to cigarette use among PWHC. Qualitative data from two focus groups of PWHC reporting current cigarette smoking (n = 15, 60% male) were collected using a semi-structured interview guide. Participants were asked about reasons for smoking, barriers to quitting smoking, and the relationship of HCV to smoking. Focus groups were transcribed verbatim and coded in NVivo 12. Four coders examined themes that arose in the focus groups. Common themes are described and supported with quotes. Results: Reasons for smoking included addiction to cigarettes, stress, substituting cigarettes for other drugs, and social norms, while reasons for quitting included health and being free from the use of all drugs. Barriers to quitting included concerns about coping with stress, weight gain, and having a lack of support for and education about quitting. Many participants believed there was a link between smoking and HCV and discussed smoking in relation to the stress of an HCV diagnosis. Conclusions: Participants identified both HCV-related and non-HCV-related aspects of cigarette smoking and cessation-related behaviors that could be targeted in cessation treatment. More research is needed to identify the best treatment approaches that reduce the significant medical consequences of cigarette use among PWHC. Implications: People with chronic hepatitis C virus (HCV; PWHC) smoke cigarettes at a high prevalence, yet little is known about their smoking behaviors. Moreover, there are no cessation treatments targeting PWHC. This is the first study to collect focus group data from PWHC who smoke in order to identify reasons for cigarette use (HCV-related and non-HCV-related), and motivators and barriers to quitting cigarettes. PWHC reports using cigarettes to cope with the stress of an HCV diagnosis and to celebrate HCV cure. These findings suggest there are specific times during the HCV care continuum where providers can aid with cessation efforts.Keywords
Funding Information
- NIH/NIDA (K24-DA034621)
This publication has 45 references indexed in Scilit:
- A National Hepatitis C Elimination Program in the United StatesJAMA, 2023
- Nicotine and opioid co-dependence: Findings from bench research to clinical trialsNeuroscience & Biobehavioral Reviews, 2022
- Tobacco, Cigarettes, and the Liver: The Smoking GunJournal of Clinical and Experimental Hepatology, 2021
- HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study)AIDS and Behavior, 2021
- Dose-Response Association of Low-Intensity and Nondaily Smoking With Mortality in the United StatesJAMA Network Open, 2020
- Cigarette Smoking in Persons Living with Hepatitis C: The National Health and Nutrition Examination Survey (NHANES), 1999-2014The American Journal of Medicine, 2018
- Association of Long-term, Low-Intensity Smoking With All-Cause and Cause-Specific Mortality in the National Institutes of Health–AARP Diet and Health StudyJAMA Internal Medicine, 2017
- Targeting cessation: Understanding barriers and motivations to quitting among urban adult daily tobacco smokersAddictive Behaviors, 2013
- Strategies to increase the delivery of smoking cessation treatments in primary care settings: A systematic review and meta-analysisPreventive Medicine, 2010
- The impact of smoking cessation on drug abuse treatment outcomeAddictive Behaviors, 2003